Belgian Consensus Recommendations to Prevent Vitamin K Deficiency Bleeding in the Term and Preterm Infant

Area of Science:

• Neonatal Medicine
• Pediatrics
• Pharmacology

Background:

• Vitamin K prophylaxis is crucial for preventing vitamin K deficiency bleeding (VKDB) in newborns.
• Current practices for neonatal vitamin K prophylaxis vary significantly across departments.
• Established benefits of vitamin K prophylaxis compared to placebo are well-documented.

Purpose of the Study:

• To review and compare different vitamin K prophylaxis regimens regarding VKDB incidence.
• To collect data on current practices in Belgian pediatric and neonatal departments.
• To develop a consensus-based recommendation for harmonized vitamin K prophylaxis.

Main Methods:

• Conducted a literature review comparing vitamin K regimens and their efficacy in preventing VKDB.
• Gathered information on current vitamin K prophylaxis practices from Belgian pediatric and neonatal units.
• Developed and voted on a consensus recommendation involving co-authors and department heads.

Main Results:

• Practices for neonatal vitamin K prophylaxis are currently inconsistent.
• The literature supports a 1 or 2 mg intramuscular (IM) vitamin K dose at birth as the primary prophylactic regimen.
• Alternative oral or intravenous (IV) regimens are outlined for specific situations, including parental refusal and preterm infants.

Conclusions:

• A consensus recommendation for vitamin K prophylaxis has been established to promote harmonization.
• The primary recommended regimen is 1-2 mg IM vitamin K at birth.
• Specific guidelines are provided for preterm infants and situations involving parental refusal, emphasizing oral or IV alternatives.